EN DE

Integrated Research Limited (IREHF) Fair Value & Analysis

Technology · US · Market cap $32.5M

IR Integrated Research Limited logo Integrated Research Limited IREHF · US
Price$0.2000
Fair Value$0.1679
Upside-16.1%
Quality65/100
Watch Integrated Research Limited for free, get notified when fair value or trend changes. Watch for free
Weak Growth
Solidly profitable · 10.7% net margin
generates free cash flow
11.11% dividend yield
Ranks above peers (10/13)
Narrow moat 39/100
Evidence: High Range $0.1189 – $0.2303 Share as image

Fair value as of: Aug 13, 2026

From 25 valuation models · updated today

Fair value updated Aug 13, 2026, revised from $1.07 to $0.1679 (−84.3%) since Jul 31, 2026. Share price +11.1% over the past month.

A solid business, but screening 16% overvalued on our models.

What matters now

  • Solid but not exceptional quality (65/100) and above fair value, neither a clear bargain nor a standout compounder.
  • A fairly wide model range ($0.1189 to $0.2303) leaves room in how you read the outcome.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

$1.73 $0.1800 Fair Value $0.1679 Apr 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.

How to read this chart

60‑month range $0.1800 – $1.73 · fair‑value band $0.1189 – $0.2303 · the $0.2000 price screens above the $0.1679 fair value. Dashed = 300-day average. As of Aug 13, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Integrated Research Limited (IREHF) currently trades at $0.2000, while our model-based Fair Value estimate is $0.1679, implying the stock looks roughly 16.1% overvalued today. The Quality Score stands at 65/100 (solid quality), in the Technology sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).

Over the trailing twelve months, Integrated Research Limited generated revenue of $67.8M at a net margin of 10.7%. Revenue declined 1.7% year over year. It earns a return on equity of 7.7%. The balance sheet holds a net cash position of $38.7M. Fundamentals as of Aug 13, 2026

Our scenario range runs from $0.1189 (bear case) to $0.2303 (bull case); at $0.2000, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 40% below its 52-week high and 12% above its 52-week low, currently below its 200-day average. For context, the median of 10 Technology peers we cover trades at -40% fair-value upside, at -16%, IREHF screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Residual Income $0.4800 $0.5400 $0.8300 76
Growth DCF $0.5900 $0.7000 $0.8200 72
Gordon GGM $0.1300 $0.2200 $0.2900 70
All 25 models by family
DCF Models
FCF DCF $0.5900 $0.7100 $0.8500 38
Owner Earnings $0.8100 $1.01 $1.24 31
5Y Revenue Exit $0.7400 $1.03 $1.41 39
5Y EBITDA Exit $0.8900 $1.30 $1.78 41
5Y P/E Exit $1.14 $1.76 $2.40 38
10Y Revenue Exit $0.6500 $0.8800 $1.16 36
10Y EBITDA Exit $0.7400 $1.03 $1.40 37
10Y P/E Exit $0.8800 $1.30 $1.79 35
Earnings-Based
Graham-Dodd $0.5000 $1.32 $1.72 54
PEG = 1.0 $0.2500 $0.3600 $0.4700 46
EPV $0.5500 $0.5900 $0.6200 59
Dividend Discount
Gordon GGM $0.1300 $0.2200 $0.2900 70
DDM Multi-Stage $0.1300 $0.1900 $0.2400 61
Multiples
P/E Multiple $1.55 $2.07 $2.59 63
P/S Multiple $0.9400 $1.26 $1.57 58
P/B Multiple $0.9400 $1.26 $1.57 55
EV/EBIT $1.56 $2.00 $2.45 53
EV/EBITDA $1.26 $1.60 $1.94 54
EV/Revenue $0.9000 $1.19 $1.48 43
Asset-Based
NCAV (Graham) $0.2800 $0.3700 $0.5600 50
Growth DCF
Growth DCF $0.5900 $0.7000 $0.8200 72
Rev-Margin DCF $0.7400 $1.03 $1.36 67
Economic Profit
Residual Income $0.4800 $0.5400 $0.8300 76
ROIC Compounder $0.5500 $0.6000 $0.6500 67
Growth Earnings
Growth-Adj P/E $1.19 $1.70 $2.21 68

Widest divergence: Growth Earnings ($1.70) versus Dividend Discount ($0.1900). Highest evidence: Residual Income (76).

Notify me when IREHF reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) $67.8M
Revenue growth (YoY) -1.7%
Net margin 10.7%
Return on equity 7.7%
Free cash flow $8.2M FY2025
P/E ratio 6.7
More key figures
Operating margin -11.9%
EPS (TTM) $0.0300
Dividend yield 11.1%
EPS growth (YoY) -44.5%
Net cash $38.7M FY2025

Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 65/100

Of which business quality 67 · Market factors (momentum, volatility) 33

Profitability 67
Margins and returns on capital today
Quality Growth 10
Are margins and returns improving?
Cashflow 54
Earnings quality: real cash, not paper profit
Fin. Strength 100
Balance sheet, leverage, solvency risk
Investment 92
Disciplined investing over empire-building
Low Volatility 41
Calm price path (market factor)
Momentum 36
Price trend over the last 3–12 months (market factor)
52W Momentum 20
Distance to the 52-week high (market factor)
Net Issuance 72
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Integrated Research Limited designs, develops, implements, and sells software for business-critical computing, unified communication, and payment networks.

Full company description

Integrated Research Limited designs, develops, implements, and sells software for business-critical computing, unified communication, and payment networks. The company offers Prognosis, an integrated suite of monitoring and management software designed to give an organization's management and technical personnel operational insight into the HP NonStop platform, distributed system servers, unified communications, payment environments, and business applications. It also provides licensing, testing, maintenance, and professional services, as well as software-as-a-service solutions. In addition, it offers enterprise UC, contact centers, customer experience testing, and collaboration space management services, as well as high-value payments, card payments, and real-time payments-related products and services. It serves banks, credit card companies, telecommunications carriers, technology companies, service providers, and manufacturers. Integrated Research Limited was incorporated in 1988 and is based in Sydney, Australia.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Integrated Research Limited reported revenue of $68.3M in FY2025 versus $78.5M in FY2021, a compound −3.4%/yr. Reported net income was $13.4M in FY2025, compounding +13.9%/yr from FY2021.

Growth Quality 40/100
Revenue growth is weak, negative or inconsistent.
Latest Revenue (FY 2025)
$68.3M
Latest YoY
−18.1%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+2.8%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
−9.3%
Avg. growth/yr (24Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+3.8%
Revenue −3.4%/yr
FY21 $78.5M
FY22 $62.9M
FY23 $69.8M
FY24 $83.3M
FY25 $68.3M
Net income +13.9%/yr
FY21 $7.9M
FY22 $1.5M
FY23 −$29.2M
FY24 $27.1M
FY25 $13.4M
Character of growth · EPS growth decomposed (2014-2025) +4.3 % p.a.
Revenue per share +0.4 pp

of which total revenue +0.9 pp · buybacks/dilution −0.5 pp

EBIT margin +1.1 pp
Tax rate +1.8 pp
Residual (interest, one-offs) +1.0 pp

Absolute contributions in percentage points per year; they sum to the EPS growth rate. Start and end points are 3-year averages (details on hover).

IREHF screens 16% overvalued. Compare with SAP SE →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Integrated Research Limited Fair Value". https://www.fairvalue-calculator.com/stock/IREHF

Peer Group

Software - Application · 713 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 65 · Above median
Fair Value upside −15% · Above median
Return on equity (TTM) 8% · Above median
Return on assets 5% · Above median
Net margin (TTM) 11% · Above median
Operating margin (TTM) -12% · Bottom 25%
Revenue growth -2% · Below median
Dividend yield (TTM) 11.1% · Top 25%

Valuation Multiples vs Software - Application median · lower = cheaper

P/E (TTM) 6.7× · Cheaper than 75% of peers
P/B 0.32× · Cheaper than 75% of peers
P/S (TTM) 0.48× · Cheaper than 75% of peers
P/FCF 4.0× · Cheaper than median
PEG 2.15× · Pricier than median

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 13 · sector 4
FUTURE 0 · sector 38
PAST 31 · sector 13
HEALTH 0 · sector 98
DIVIDEND 100 · sector 27

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Software - Application stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).

Stock Price Fair Value vs Fair Value
SAP SE SAPS C$12.46 C$16.26 +30%
Shopify Inc SHOP C$209.78 C$28.76 -86%
Uber Technologies, Inc UBER $75.36 $43.66 -42%
Salesforce, Inc CRM $193.32 $249.28 +29%
ServiceNow, Inc NOW $124.94 $43.73 -65%
Cadence Design Systems, Inc CDNS $323.13 $112.57 -65%
Beijing Kingsoft Office Software, Inc 688111 ¥254.50 ¥81.23 -68%
Tata Elxsi Limited TATAELXSI ₹3,712 ₹2,519 -32%
Douzone Bizon Co 012510 120,000 KRW 92,181 KRW -23%
KFin Technologies Limited KFINTECH ₹922.00 ₹556.85 -40%

Compare Integrated Research Limited with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Technology stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Integrated Research Limited (IREHF) overvalued or undervalued?
As of Aug 13, 2026, our model estimates a fair value of $0.1679 versus a price of $0.2000, about −16% (overvalued).
What is the fair value of IREHF?
Our model-based fair value for Integrated Research Limited is $0.1679 (as of Aug 13, 2026), built from audited fundamentals. The current price is $0.2000.
What is the quality score of IREHF?
Integrated Research Limited has a Quality Score of 65/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Integrated Research Limited (IREHF)?
Integrated Research Limited reported trailing-twelve-month revenue of about $67.8M (latest available figure, as of Aug 13, 2026).
What is the net profit margin of IREHF?
The net profit margin of Integrated Research Limited is about 10.7%, meaning it keeps roughly 10.7% of revenue as net income. Based on the latest reported figures.
Does Integrated Research Limited pay a dividend?
Integrated Research Limited currently shows a dividend yield of about 11.11% relative to its recent price (as of Aug 13, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Integrated Research Limited and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.